Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis - ScienceDirect
Hif ph inhibitors for anemia in ckd | PPT
HIF-PHIs for the Treatment of Anemia in CKD: Ready or Not? - YouTube
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury - ScienceDirect
Treating Anemia in CKD in the Era of HIFs: A Ray of Hope? - Renal Fellow Network
HIF-1α is a Potential Molecular Target for Herbal Medicine to Tr | DDDT
Mechanism of action of HIF stabilizers. Under normal conditions, the... | Download Scientific Diagram
HIF PHI Trials in CKD non-dialysis and dialysis: What do the data really show?
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
HIF prolyl-hydroxylase inhibitor - Wikipedia
Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease - Kidney International Supplements
What HIF? Leaving More Questions Than Answers – AJKD Blog
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects | Clinical and Experimental Nephrology
HIF Stabilizers Get in Sync: Are ESAs Bye Bye Bye? in: Kidney News Volume 13 Issue 3 (2021)
The HIF System Response to ESA Therapy in CKD‐Anemia | IntechOpen
Anemia of Chronic Kidney Disease: Will New Agents Deliver on Their Promise?
HIF-1 as a target for drug development | Nature Reviews Drug Discovery
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
Molecules | Free Full-Text | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
